CAS: 1715025-32-3
| Brand | Product data | Purity | Price range | Estimated delivery |
|---|---|---|---|---|
 | Rineterkib REF: 54-BUP09164CAS: 1715025-32-3 | 98.39% | 877.00 €~1,921.00 € | Mon 21 Apr 25 |
 | ERK-IN-1 REF: 3D-QTC02532CAS: 1715025-32-3 | Min. 95% | To inquire | Thu 29 May 25 |
 | Rineterkib REF: TM-T11224CAS: 1715025-32-3 | 98.4% | 95.00 €~1,159.00 € | Thu 31 Jul 25 |
Ref: 54-BUP09164
| 25mg | 877.00 € | ||
| 50mg | 1,153.00 € | ||
| 100mg | 1,570.00 € | ||
| 200mg | 1,921.00 € |
Estimated delivery in United States, on Monday 21 Apr 2025
ERK-IN-1
CAS:1715025-32-3
Please enquire for more information about ERK-IN-1 including the price, delivery time and more detailed …
Formula:
C26H27BrF3N5O2
Purity:
Min. 95%
Molecular weight:
578.4 g/mol
Ref: 3D-QTC02532
| 5mg | 593.00 € | ||
| 10mg | 899.00 € | ||
| 25mg | 1,588.00 € | ||
| 50mg | 2,474.00 € |
Estimated delivery in United States, on Thursday 29 May 2025
Rineterkib
CAS:1715025-32-3
Rineterkib (ERK-IN-1) is an inhibitor of RAF and ERK1/2 activating mutations in the MAPK pathway.
Formula:
C26H27BrF3N5O2
Purity:
98.4%
Color and Shape:
Solid
Molecular weight:
578.42
Ref: TM-T11224
| 1mg | 95.00 € | ||
| 5mg | 188.00 € | ||
| 10mg | 354.00 € | ||
| 25mg | 597.00 € | ||
| 50mg | 852.00 € | ||
| 100mg | 1,159.00 € | ||
| 1mL*10mM (DMSO) | 249.00 € |
Estimated delivery in United States, on Thursday 31 Jul 2025
